401 The incidence of antimuscarinic-associated side effects in overactive bladder (OAB) patients treated with mirabegron: Results of a pooled analysis of 3 randomised phase 3 trials
| Autor: | Nitti, V., Chapple, C.R., Amarenco, G., Radziszewski, P., Angulo, J., Blauwet, M.B., Siddiqui, E., Martin, N. |
|---|---|
| Zdroj: | In European Urology Supplements March 2013 12(1):e401-e402 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect